How do you interpret renin and aldosterone (Angiotensin-Converting Enzyme) lab results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Interpret Renin and Aldosterone Labs

Primary Purpose: Screening for Primary Aldosteronism

The aldosterone-to-renin ratio (ARR) is the recommended screening test for primary aldosteronism, calculated by dividing plasma aldosterone concentration (ng/dL) by plasma renin activity (ng/mL/h), with a positive screen defined as ARR ≥30 AND plasma aldosterone ≥10 ng/dL. 1, 2

When to Order These Tests

Screen patients with any of the following high-risk features:

  • Resistant hypertension (BP uncontrolled on 3 medications including a diuretic) 1, 2
  • Severe hypertension (BP >180/110 mmHg) 1, 2
  • Hypokalemia (spontaneous or diuretic-induced), though notably absent in 50% of primary aldosteronism cases 2
  • Incidentally discovered adrenal mass 2
  • Family history of early-onset hypertension or stroke at age <40 years 2

Primary aldosteronism affects up to 20% of patients with resistant hypertension and up to 12% of those with severe hypertension, yet screening rates remain dismally low at only 2-4% of eligible patients. 1, 2

Patient Preparation: Critical for Accurate Interpretation

Medication Management

Two approaches exist, and you must choose based on clinical context:

Approach 1 (Pragmatic): Test patients on their current medications and interpret results in context of those medications. 1 This reduces barriers to screening and avoids dangerous BP fluctuations in poorly controlled patients. 1

Approach 2 (Ideal): Discontinue interfering medications when clinically feasible:

  • Stop these drugs (they suppress renin and cause false-positives): Beta-blockers, centrally acting drugs (clonidine, methyldopa), and diuretics 1, 3
  • Use these instead: Long-acting calcium channel blockers (dihydropyridine or non-dihydropyridine) and alpha-receptor antagonists minimally interfere with ARR 1, 2
  • Caution with ACE inhibitors/ARBs: These elevate renin and can cause false-negatives 4, 3, 5

Beta-blockers increase ARR by 62% on average, potentially causing false-positives, while ACE inhibitors and ARBs decrease ARR by 30-43%, risking false-negatives. 3, 5

Other Preparation Requirements

  • Correct hypokalemia first - it suppresses aldosterone production and causes false-negatives 2, 4
  • Ensure unrestricted salt intake - sodium status affects interpretation 1, 2
  • Timing matters: Collect blood in the morning after patient has been out of bed for 2 hours and seated for 5-15 minutes 2

Interpreting the Results

Pattern 1: High Aldosterone, Low Renin (High ARR)

This suggests primary aldosteronism when ARR ≥30 AND aldosterone ≥10 ng/dL. 1, 2

Critical caveat: The ARR has significant limitations. Research shows sensitivity of only 22-66% and specificity of 67-99% depending on the population and medications. 6, 5 The test becomes increasingly unreliable as ARR values rise due to marked variability. 7

Next steps:

  1. Confirmatory testing is mandatory - never diagnose based on ARR alone 1, 2
  2. Options include:
    • IV saline suppression test (2L normal saline over 4 hours; failure to suppress aldosterone <5 ng/dL confirms diagnosis) 2
    • Oral salt loading with 24-hour urine aldosterone measurement 1, 2
  3. Refer to endocrinology or hypertension specialist for confirmatory testing and subtype determination 2, 4

Pattern 2: High Aldosterone, High Renin (Normal or Low ARR)

This suggests secondary hyperaldosteronism, most commonly from renovascular hypertension. 4

Evaluate for:

  • Renal artery stenosis using renal artery duplex ultrasound or CT angiography 4
  • Clinical clues: Flash pulmonary edema, asymmetric kidney size, severe/refractory hypertension 4
  • Medication effects: Diuretics, ACE inhibitors, ARBs, and beta-blockers all elevate renin 4

Management: Medical therapy is first-line for atherosclerotic renal artery stenosis, as revascularization shows no benefit over medical management in most cases. 4 Consider revascularization only for refractory hypertension despite optimal medical therapy, progressive renal decline, flash pulmonary edema, or fibromuscular dysplasia. 4

Pattern 3: Low Aldosterone, High Renin

This pattern is not consistent with primary aldosteronism and suggests volume depletion, diuretic use, or other causes of secondary hyperreninemia. 1

Pattern 4: Low Aldosterone, Low Renin

Consider adrenal insufficiency or other causes of hypoaldosteronism in the appropriate clinical context.

Common Pitfalls to Avoid

  • Don't rely on hypokalemia - it's absent in 50% of primary aldosteronism cases 2
  • Don't skip confirmatory testing - ARR alone has poor reproducibility with up to 5-fold variation between measurements taken under identical conditions 7, 5
  • Don't proceed to surgery based on CT findings alone - adrenal venous sampling is mandatory before adrenalectomy, as CT leads to inappropriate surgery in 25% of cases 2, 4
  • Don't forget mineralocorticoid receptor antagonists - withdraw at least 4 weeks before testing 1, 2
  • Don't interpret isolated high ARR as diagnostic - in 36% of cases, elevated ARR reflects low renin alone without truly elevated aldosterone 6

Units and Cut-offs

ARR cut-offs vary by laboratory and units used. 1 The standard cut-off of ≥30 applies when aldosterone is measured in ng/dL and renin activity in ng/mL/h. 2 Some sources use alternative cut-offs (≥20 or different units), so always verify your local laboratory's reference ranges. 2, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Screening for Primary Aldosteronism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperaldosteronism with Elevated Plasma Renin Activity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.